| Nicholas Louis Bormann, MD | |
|
404 Fountain St, Albert Lea, MN 56007-2406 | |
| (507) 373-2384 | |
| Not Available |
| Full Name | Nicholas Louis Bormann |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 6 Years |
| Location | 404 Fountain St, Albert Lea, Minnesota |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750879367 | NPI | - | NPPES |
| 1750879367 | Medicaid | IA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System - Albert Lea And Austin | Albert lea, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).
Syngenta Biotechnology Inc. has announced that it has entered into a research and commercial license agreement for Chromatin's proprietary gene stacking technology.
Lots of work is being done to recognise and control infections such as community acquired MRSA and the UK is learning from situations in community and healthcare settings both here and abroad to stay ahead of the game, scientists will be told today at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
› Verified 2 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).
Syngenta Biotechnology Inc. has announced that it has entered into a research and commercial license agreement for Chromatin's proprietary gene stacking technology.
Lots of work is being done to recognise and control infections such as community acquired MRSA and the UK is learning from situations in community and healthcare settings both here and abroad to stay ahead of the game, scientists will be told today at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).
Syngenta Biotechnology Inc. has announced that it has entered into a research and commercial license agreement for Chromatin's proprietary gene stacking technology.
Lots of work is being done to recognise and control infections such as community acquired MRSA and the UK is learning from situations in community and healthcare settings both here and abroad to stay ahead of the game, scientists will be told today at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Louis Bormann, MD 408 W Fountain St, Albert Lea, MN 56007-2437 Ph: (507) 377-6411 | Nicholas Louis Bormann, MD 404 Fountain St, Albert Lea, MN 56007-2406 Ph: (507) 373-2384 |
News Archive
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).
Syngenta Biotechnology Inc. has announced that it has entered into a research and commercial license agreement for Chromatin's proprietary gene stacking technology.
Lots of work is being done to recognise and control infections such as community acquired MRSA and the UK is learning from situations in community and healthcare settings both here and abroad to stay ahead of the game, scientists will be told today at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
› Verified 2 days ago
Tyler Scott Oesterle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Mchs-albert Lea Austin, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Ammar Alam, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-6285 | |
Karen M Gosen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-2384 |